Page 188 - Critical Care Notes
P. 188

4223_Tab06_175-198  29/08/14  8:27 AM  Page 182



                                          GI
          ■ Repeated environmental and hepatotoxin exposure
          ■ Malignancy
          ■ Hypoperfusion of the liver
          ■ Metabolic disorders: Reye’s syndrome, Wilson’s disease
          ■ Autoimmune disorders
          ■ Malnutrition, diabetes mellitus, chronic cholestatic disease, and
            hypertriglyceridemia
          ■ Postoperatively: jejunoileal bypass, partial hepatectomy, liver transplant failure
                           Pathophysiology
          ■ Severe liver impairment such as necrosis or ↓ blood supply to liver → toxic
            substances accumulating in the blood.
          ■ Impaired bilirubin conjugation, ↓ clotting factors, ↓ glucose synthesis,
            ↓ lactate clearance → jaundice, coagulopathies, hypoglycemia, and
            metabolic acidosis.
          ■ Decreased macrophages in liver →↑ risk of infection and spleen enlargement.
          ■ Hypoalbuminemia, fluid and electrolyte imbalances, acute portal hyperten-
            sion → development of ascites.
          ■ Ineffective fat metabolism →↓ bile salt production.
          ■ Cirrhosis: Fibrotic tissue replaces healthy liver tissue.
          ■ Fatty liver disease: Fatty cells replace healthy liver tissue.
          ■ Hepatic failure may progress to hepatic encephalopathy.
                         Clinical Presentation
          ■ Jaundice and pruritus, ascites, edema, JVD
          ■ Abdominal pain
          ■ Malnutrition, nausea, vomiting, and anorexia
          ■ Weakness, fatigue, and confusion
          ■ Hyperventilation, respiratory alkalosis, dyspnea, pleural effusion, crackles,
            and hypoxemia
          ■ Hypokalemia and hyponatremia or hypernatremia
          ■ Palmar erythema, spider nevi, spider angiomas, and bruising; patient prone
            to bleeding
          ■ Asterixis: Liver flap (patient extends arms → wrist dorsiflexes downward
            involuntarily)
          ■ Metabolic acidosis, hypoglycemia, hypokalemia, and hyponatremia
          ■ Gallstones, malnutrition, light or clay-colored stools, and dark urine
          ■ Diarrhea and steatorrhea (fatty, greasy, foul-smelling stools)
          ■ Hepatic encephalopathy: Drowsiness, confusion, delirium or coma, inappro-
            priate behavior, fetor hepaticus (sweet, slightly fecal breath odor), and day-
            night reversal
                                182
   183   184   185   186   187   188   189   190   191   192   193